Bottom line
HIAHX vs RYHIX: the short answer
HIAHX (Hartford Healthcare Hls Fund) and RYHIX (Health Care Fund) are both mutual funds.
HIAHX is cheaper at 0.94% vs 1.38% — a difference of $44 a year per $10,000 invested.
Over five years, RYHIX returned +5.1% a year vs +3.5% for HIAHX.
Updated Nov 19, 2026
HIAHX vs RYHIX side by side
| HIAHX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Hartford | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.94% | 1.38% |
| Annual cost per $10k | $94 | $138 |
| 10-yr cost on $10k (prospectus) | $1,155 | $1,709 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.1% | +14.4% |
| 5-yr return (annualized) | +3.5% | +5.1% |
| 10-yr return (annualized) | +7.9% | +7.9% |
| Best quarter | +21.0% | +18.7% |
| Worst quarter | −15.6% | −14.4% |
| Net assets (fund) | $112.4M | $19.4M |
| Number of holdings | 79 | 135 |
| Portfolio turnover | 5% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HIAHX | RYHIX | Difference |
|---|---|---|---|
| 2025 | +16.1% | +14.4% | +1.7% |
| 2024 | +0.4% | +0.6% | −0.2% |
| 2023 | +4.1% | +5.8% | −1.7% |
| 2022 | −11.2% | −11.6% | +0.4% |
| 2021 | +10.0% | +19.2% | −9.2% |
| 2020 | +23.1% | +18.9% | +4.2% |
| 2019 | +34.0% | +22.8% | +11.2% |
| 2018 | −2.7% | +1.6% | −4.2% |
| 2017 | +22.3% | +23.5% | −1.2% |
| 2016 | −8.4% | −9.4% | +1.0% |
Source: Fund prospectus bar charts
Holdings overlap
18 of HIAHX's top 25 holdings also appear in RYHIX's top 25.
| Holding | HIAHX | RYHIX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 3.63% |
| Johnson & Johnson | 6.63% | 2.88% |
| Merck & Co Inc | 6.60% | 2.04% |
| UnitedHealth Group Inc | 4.72% | 2.22% |
| AbbVie Inc | 3.43% | 2.52% |
| Intuitive Surgical Inc | 2.99% | 1.31% |
| Elevance Health Inc | 2.96% | 1.02% |
| CVS Health Corp | 2.93% | 1.31% |
| Vertex Pharmaceuticals Inc | 2.69% | 1.34% |
| Danaher Corp | 2.65% | 1.30% |
| Edwards Lifesciences Corp | 2.42% | 0.84% |
| Abbott Laboratories | 2.10% | 1.42% |
| Cardinal Health Inc | 1.81% | 0.86% |
| Thermo Fisher Scientific Inc | 1.64% | 1.61% |
| HCA Healthcare Inc | 1.60% | 0.87% |
Source: SEC Form N-PORT
HIAHX top 10
- Eli Lilly & Co — 12.47%
- Johnson & Johnson — 6.63%
- Merck & Co Inc — 6.60%
- UnitedHealth Group Inc — 4.72%
- AbbVie Inc — 3.43%
- Intuitive Surgical Inc — 2.99%
- Elevance Health Inc — 2.96%
- CVS Health Corp — 2.93%
- Vertex Pharmaceuticals Inc — 2.69%
- Danaher Corp — 2.65%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between HIAHX and RYHIX?
Which is cheaper, HIAHX or RYHIX?
Should I own both HIAHX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.